Duovir N Lamivudine Zidovudine and Nevirapine Tablets

Duovir N Lamivudine Zidovudine and Nevirapine Tablets Specification

Origin of Medicine
India

Indication
Treatment of HIV-1 infection

Packaging Type
Bottle

Life Span
24 to 36 months (check label for exact expiry)

Pacakaging (Quantity Per Box)
60 Tablets per bottle/pill container

Dosage Form
Solid

Salt Composition
Lamivudine 150mg, Zidovudine 300mg, Nevirapine 200mg

Brand Name
Duovir N

Drug Type
Allopathic

Ingredients
Lamivudine, Zidovudine, Nevirapine

Physical Form
Tablets

Function
Antiretroviral therapy for HIV

Recommended For
HIV infected patients

Dosage
As prescribed by the physician

Dosage Guidelines
Take exactly as prescribed, usually twice daily

Suitable For
Adults

Storage Instructions
Store in a cool, dry place below 30C. Protect from light and moisture.

Product Code
DUOVIRN60

Tablet Marking
DUOVIR N imprint

Shape
Capsule-shaped Tablets

Intended Market
Global; especially developing countries with high HIV prevalence

Patient Population
Not recommended for children under 12 years

Regulatory Approvals
DCGI (Drugs Controller General of India) approved

Side Effects
May cause rash, nausea, headache, fatigue, anemia, liver dysfunction

Contraindications
Hypersensitivity to any of the components

Color
White

Country of License
India

Controlled Substance
No

Administration Route
Oral

Prescription Status
Prescription only

WHO Prequalified
Yes

Duovir N Lamivudine Zidovudine and Nevirapine Tablets Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About Duovir N Lamivudine Zidovudine and Nevirapine Tablets

Packaging Size	60 Tablets/ Bottle
Manufacturer	Cipla
Brand	Duovir N
Packaging Type	Box
Salt	Lamivudine Zidovudine and Nevirapine
Treatment	To Treat HIV to manage or Treat AIDS

Duovir-N is an antiretroviral formulation manufactured by Cipla Limited, an award-winning Indian pharmaceutical company. The medicine effectively manages human immunodeficiency virus (HIV) infections, with each tablet containing 150mg of lamivudine, 300mg of zidovudine, and 200mg of nevirapine.